9 results
424B3
CRGX
CARGO Therapeutics, Inc. Common Stock
12 Aug 24
Prospectus supplement
4:53pm
dependent on our ability to discover, develop and obtain regulatory approval for new and innovative products on a cost-effective basis and to market … of coverage for new or innovative devices or drug therapies before they will reimburse healthcare providers who use such therapies. It is difficult
10-K
2023 FY
CRGX
CARGO Therapeutics, Inc. Common Stock
21 Mar 24
Annual report
4:21pm
and rapid technological change. Our success is highly dependent on our ability to discover, develop and obtain regulatory approval for new and innovative … will be covered. Some third-party payors may require pre-approval of coverage for new or innovative devices or drug therapies before they will reimburse
424B4
CRGX
CARGO Therapeutics, Inc. Common Stock
13 Nov 23
Prospectus supplement with pricing info
4:31pm
dependent on our ability to discover, develop and obtain regulatory approval for new and innovative products on a cost-effective basis and to market them … of coverage for new or innovative devices or drug therapies before they will reimburse healthcare providers who use such therapies. It is difficult
S-1
56e4fb
20 Oct 23
IPO registration
4:07pm
DRS/A
dx809i 514r2xm97
4 Oct 23
Draft registration statement (amended)
12:00am
DRS
nx616t3rz8r apousx0
1 Sep 23
Draft registration statement
12:00am
- Prev
- 1
- Next